[Histonet] MGH Neuropath

[Goolsby, Holly]

I'd like to let everyone know that MGH Neuropath moved, but never liquidated!

Here are some thoughts on Hydroquinone & Lithium Carbonate:  Tim, the MGH
protocol says that either Hydroquinone or Lithium Carbonate can be used.  I
think that came from the original lab handbook by DR's Kubik & Richardson.  The
Kluver-Barrera method uses Lithium Carbonate as from the 1957 AFIP manual and
the Holmes Luxol Fast Blue uses the Hydroquinone & Sodium Sulfite.  This was a
step taken from Bodian procedure.  

I started using Lithium Carbonate several years ago when I went to use the
Hydroquinone/sodium sulfite solution, I discovered that it had turned brown.  I
didn't have time to remake the solution, so I used the Lithium Carbonate and it
worked beautifully.  Maybe Kubik & Richardson had the same emergency,

I use a super saturated Lithium Carbonate stock  solution.  Dilute 1:1 before
use and filter and use for differentiating the slides after their incubation in
Luxol Fast Blue.   Harris hematoxylin for 3 min, acid ETOH, lithium carbonate
again and then 1% alcoholic eosin with 0.5% acetic acid for 3 min and then into
100% ETOH x 3, xylene x 3.  

Gill hematoxylin gives poor results for this stain. 

One last note:  pay attention to the washing steps after acid alcohol & lithium
carbonate.  If not washed for a few minutes between steps, the slides will fade
over time.

Holly A. Goolsby, HT(ASCP)
Sr. Tech Specialist, Neuropathology
Pathology, Blake 350 B
Massachusetts General Hospital
Fruit Street
Boston, MA  02114
 
hgoolsby <@t> partners.org <mailto:hgoolsby <@t> partners.org>
617-726-3798
fax:  617-726-6829







THE INFORMATION TRANSMITTED IN THIS ELECTRONIC COMMUNICATION IS INTENDED ONLY FOR THE PERSON OR ENTITY TO WHOM IT IS ADDRESSED AND MAY CONTAIN CONFIDENTIAL AND/OR PRIVILEGED MATERIAL.  ANY REVIEW, RETRANSMISSION, DISSEMINATION OR OTHER USE OF OR TAKING OF ANY ACTION IN RELIANCE UPON, THIS INFORMATION BY PERSONS OR ENTITIES OTHER THAN THE INTENDED RECIPIENT IS PROHIBITED.  IF YOU RECEIVED THIS INFORMATION IN ERROR, PLEASE CONTACT THE SENDER AND THE PRIVACY OFFICER, AND PROPERLY DISPOSE OF THIS INFORMATION.